Alzheimer's-related protein disrupts motors of cell transport
May 2, 2011 in Medical researchA protein associated with Alzheimer's disease clogs several motors of the cell transport machinery critical for normal cell division, leading to defective neurons that may contribute to the memory-robbing disease, University of South Florida researchers report.
In a new study published online in the journal Cell Cycle, scientists at the USF Health Byrd Alzheimer's Institute. the Florida Alzheimer's Disease Research Center, and Indiana University also suggest that the protein beta amyloid (amyloid protein) may cause neurons in the brain to malfunction and directly contribute to the memory loss that accompanies Alzheimer's progression. The experiments were conducted using human cell cultures and frog egg extracts.
This video is not supported by your browser at this time.
This time-lapse video depicts what happens to a mitotic spindle exposed to beta amyloid, a protein associated with Alzheimer's disease. In normal cell division, the red microtubules would stretch out and pull DNA (blue) to opposite ends of the structure. Instead, the microtubules shown here are disrupted and the DNA gets badly mis-localized and lost from the spindle. The result can be an abnormal assortment of genes. Credit: © University of South Florida
"By identifying a brand new and extremely important target of the amyloid protein's toxicity, we can develop drugs for Alzheimer's disease that may protect the motors from inhibition and allow the brain to regenerate properly," said principal investigator Huntington Potter, PhD, a professor of Molecular Medicine who holds the Pfeiffer Endowed Chair for Alzheimer's Disease Research.The latest study builds upon earlier research by Dr. Potter and colleagues showing that the amyloid protein is the culprit that damages the microtubule transport system responsible for moving chromosomes, proteins and other cargo around inside cells. The microtubules are critical for segregating newly duplicated chromosomes as cells divide. When the duplicated chromosomes don't separate properly, they can re-assemble inside newly created cells in wrong numbers and with an abnormal assortment of genes.
More than 20 years ago Dr. Potter created a storm of controversy with the idea that Down syndrome and Alzheimer's were the same disease. Not only did all people with Down syndrome over age 30 develop the same brain pathology seen in Alzheimer's but perhaps both diseases shared the abnormality of having three copies of chromosome 21, which carries the beta amyloid gene.
Subsequent studies by Dr. Potter and others indicated that Alzheimer's disease was indeed promoted in part by the development of new trisomy 21 cells in the brain, which amplify the nerve-killing buildup of sticky amyloid protein clumps.
The findings in Cell Cycle help to further delineate how interference with cell division could result in a cascade of events that contributes to Alzheimer's pathology. In a series of laboratory experiments, several neuroscientists and cell biologists collaborated to demonstrate how over-production of the amyloid protein attacks several molecular motors that play a role in moving chromosomes along microtubules during normal cell division.
"It's kind of like throwing sand in the gears of the cell's transport machinery," said first author Sergiy Borysov, PhD, a postdoctoral fellow in Dr. Potter's laboratory. "It keeps the wheels from moving, which interferes with the cell division cycle and ultimately leads to the production of degeneration-prone neurons seen in the Alzheimer's disease brain."
The same motors are essential for neuron function as well as production, the researchers suggest.
Properly functioning microtubule motors are especially critical in nerve cells, in which molecules related to learning and memory must travel over long distances, Dr. Potter said. Identifying specific microtubule motors directly inhibited by the amyloid protein could help researchers develop more effective drugs or other therapies for Alzheimer's disease, he added.
More information: "Alzheimer's Aβ Disrupts the Mitotic Spindle and Directly Inhibits Mitotic Microtubule Motors;" Sergiy I. Borysov, Antoneta Granic, Jaya Padmanabhan, Claire E. Walczak, and Huntington Potter, Cell Cycle, Volume 10, Issue 9 (May 2011).
Provided by University of South Florida
-
Studies demonstrate link among Alzheimer's disease, Down syndrome and atherosclerosis
Jan 16, 2010 |
not rated yet |
0
-
How culprit Alzheimer's protein wreaks havoc
Mar 28, 2011 |
not rated yet |
0
-
Scientists find new cause of Alzheimer's
Apr 19, 2006 |
not rated yet |
0
-
QBI neuroscientists make Alzheimer's disease advance
Jun 10, 2008 |
not rated yet |
0
-
Scientists identify a new target for Alzheimer's disease
Sep 21, 2010 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
7 hours ago |
5 / 5 (1) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Math and dyslexia?
17 hours ago
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
-
A couple of questions about schizophrenia
May 17, 2012
-
Paralyzed woman uses thoughts to move robotic arm
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Researchers spearhead groundbreaking research into treatment of brain swelling
Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury ...
Medical research
3 hours ago |
not rated yet |
0
|
FDA clears test for mastocytosis diagnosis
The Food and Drug Administration has approved a new test to help physicians diagnose a group of rare cell disorders. The test, or assay, was developed by an expert at Virginia Commonwealth University in the field of mast ...
Medical research
3 hours ago |
not rated yet |
0
Novel biomarkers reveal evidence of radiation exposure
Researchers at the Medical College of Wisconsin have identified novel biomarkers that could be used to confirm exposure to damaging radiation in large groups of people potentially exposed to unknown and variable doses for ...
Medical research
3 hours ago |
not rated yet |
0
Stem cell research paves way for progress on dealing with Fragile X retardation
Researchers at the Hebrew University of Jerusalem have achieved, for the first time, the generation of neuronal cells from stem cells of Fragile X patients. The discovery paves the way for research that will examine restoration ...
Medical research
5 hours ago |
not rated yet |
0
Limits to growth: Scientists identify key metastasis-enabling enzyme
(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...
Medical research
7 hours ago |
5 / 5 (1) |
0
|
Scientists unravel role of fusion gene in prostate cancer
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...
Early-life risk factors for non-Hodgkin lymphoma
Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published May 22 in the Journal of ...
Studies examine CPAP treatment and cardiovascular outcomes in adults with obstructive sleep apnea
Two studies that included adults with obstructive sleep apnea examined the effectiveness of reducing the risk of cardiovascular outcomes, including high blood pressure, by treatment with continuous positive airway pressure ...
Systems treating severe heart attacks expanding nationwide
The number of systems of care that quickly transfer and treat heart attack patients has increased substantially across the nation, according to research published in Circulation: Cardiovascular Quality and Outcomes, an American ...
Use of multicomponent intervention linked with decrease in using physical restraint in nursing homes
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and ...
Body building, diet supplements linked to liver damage: study
(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.